BARASCH RICHARD A
SEC CIK 1076341 · EDGAR
BoughtSold
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
BARASCH RICHARD A made no open-market trades at STLN in the last 12 months.
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-07-28 | 2025-07-24 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | J - Other | $0.00 | -287.8K | 2.64M | -10% | $0 |
| DI | 2025-06-24 | 2025-06-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | F - Tax | $2.62 | -311.1K | 2.92M | -10% | -$815.2K |
| DI | 2025-06-24 | 2025-06-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | X - OptEx | $1.20 | +679.2K | 3.23M | +27% | +$815.1K |
| D | 2025-06-20 | 2025-06-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +159.5K | 1.94M | +9% | $0 |
| DI | 2025-06-20 | 2025-06-18 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +620.4K | 2.56M | +32% | $0 |
| DI | 2025-03-28 | 2025-03-26 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | P - Purchase | $1.04 | +1.36M | 1.78M | +326% | +$1.41M |
| 2024-11-25 | 2024-11-22 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +80.0K | 417.2K | +24% | $0 | |
| 2024-06-24 | 2024-06-18 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Dir | F - Tax | $9.89 | -3,559 | 438.4K | -0.8% | -$35.2K | |
| 2024-05-09 | 2024-05-07 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | F - Tax | $9.85 | -8,547 | 441.9K | -2% | -$84.2K | |
| 2024-05-02 | 2024-04-30 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +8,829 | 450.5K | +2% | $0 | |
| 2024-03-04 | 2024-02-29 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | F - Tax | $10.23 | -8,984 | 430.4K | -2% | -$91.9K | |
| 2024-03-04 | 2024-03-02 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +21.2K | 451.6K | +5% | $0 | |
| 2024-01-03 | 2023-12-29 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +22.3K | 448.6K | +5% | $0 | |
| 2024-01-03 | 2024-01-02 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | F - Tax | $7.26 | -9,226 | 439.4K | -2% | -$67.0K | |
| 2023-12-28 | 2023-12-26 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +80.0K | 337.2K | +31% | $0 | |
| 2023-11-02 | 2023-10-31 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +22.9K | 426.3K | +6% | $0 | |
| 2023-09-05 | 2023-08-31 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | F - Tax | $11.93 | -6,908 | 389.8K | -2% | -$82.4K | |
| 2023-09-05 | 2023-08-31 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +13.7K | 403.5K | +4% | $0 | |
| 2023-08-14 | 2023-06-26 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Interim CEO, Dir | A - Grant | $0.00 | +17.1K | 396.7K | +5% | $0 | |
| 2023-06-26 | 2023-06-22 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +25.6K | 379.5K | +7% | $0 | |
| M | 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | P - Purchase | $0.55 | +50.0K | 217.2K | +30% | +$27.5K |
| A | 2022-12-30 | 2022-11-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +65.2K | 207.2K | +46% | $0 |
| 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +22.7K | 164.7K | +16% | $0 | |
| DI | 2022-10-07 | 2022-10-05 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | J - Other | $0.00 | +8 | 8 | New | $0 |
| D | 2022-10-07 | 2022-10-05 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | J - Other | $0.00 | +1 | 142.0K | +0.0% | $0 |
| 2022-06-24 | 2022-06-22 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +15.0K | 353.9K | +4% | $0 | |
| 2022-03-23 | 2022-03-21 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +45.9K | 142.0K | +48% | $0 | |
| M | 2021-11-24 | 2021-11-24 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | P - Purchase | $6.92 | +5,000 | 96.1K | +5% | +$34.6K |
| M | 2021-11-24 | 2021-11-23 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | P - Purchase | $6.34 | +5,000 | 91.1K | +6% | +$31.7K |
| DA | 2021-11-18 | 2021-11-12 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | D - Sale to Iss | — | -14.9K | 85.1K | -15% | — |
| DA | 2021-11-18 | 2021-11-12 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | M - OptEx | — | +100.0K | 100.0K | New | — |
| 2021-11-18 | 2021-11-16 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | P - Purchase | $10.12 | +1,000 | 86.1K | +1% | +$10.1K | |
| D | 2021-11-16 | 2021-11-12 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | D - Sale to Iss | — | -14.9K | 85.1K | -15% | — |
| D | 2021-11-16 | 2021-11-12 | STLN | Starling Oncology, Inc. | BARASCH RICHARD A | Dir | C - Cnv Deriv | — | +100.0K | 100.0K | New | — |
| 2021-08-25 | 2021-08-23 | AHCO | AdaptHealth Corp. | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +9,017 | 338.9K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations